First Header Logo Second Header Logo

Steven Feldman

Concepts (1170)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Psoriasis
325
2021
360
80.700
Why?
Dermatologic Agents
189
2021
229
50.200
Why?
Dermatology
116
2021
164
28.750
Why?
Dermatitis, Atopic
72
2020
104
23.610
Why?
Acne Vulgaris
75
2021
96
23.350
Why?
Skin Diseases
85
2021
144
20.960
Why?
Medication Adherence
73
2020
161
20.690
Why?
Biological Products
47
2021
78
16.780
Why?
Rosacea
38
2019
46
16.280
Why?
Humans
819
2021
32297
15.720
Why?
Antibodies, Monoclonal
44
2020
250
11.250
Why?
Glucocorticoids
39
2019
161
10.880
Why?
Anti-Inflammatory Agents
39
2020
102
10.640
Why?
Severity of Illness Index
130
2020
926
10.380
Why?
Patient Compliance
47
2020
227
10.260
Why?
Skin Neoplasms
45
2020
214
9.310
Why?
Ultraviolet Therapy
34
2019
40
9.140
Why?
Phototherapy
35
2020
51
8.610
Why?
United States
197
2021
3983
8.470
Why?
Administration, Topical
84
2020
140
8.060
Why?
Administration, Cutaneous
75
2020
117
8.060
Why?
Physician-Patient Relations
38
2019
188
8.000
Why?
Quality of Life
80
2021
915
8.000
Why?
Treatment Outcome
135
2021
3358
7.880
Why?
Anti-Bacterial Agents
35
2020
309
7.650
Why?
Adrenal Cortex Hormones
30
2020
163
7.610
Why?
Skin
29
2020
217
7.530
Why?
Adult
249
2021
9467
7.510
Why?
Health Care Costs
34
2020
118
7.430
Why?
Female
320
2021
20126
7.280
Why?
Male
306
2021
19488
7.140
Why?
Patient Satisfaction
37
2020
245
7.130
Why?
Health Care Surveys
60
2020
187
6.740
Why?
Middle Aged
224
2021
11949
6.730
Why?
Patient Education as Topic
34
2019
276
6.460
Why?
Office Visits
39
2017
73
6.240
Why?
Retinoids
27
2019
41
6.050
Why?
Adolescent
136
2020
3571
5.910
Why?
Ambulatory Care
33
2018
108
5.820
Why?
Desoximetasone
10
2020
10
5.760
Why?
Clobetasol
21
2020
26
5.720
Why?
Immunosuppressive Agents
29
2020
238
5.110
Why?
Young Adult
88
2020
2626
5.110
Why?
Methotrexate
28
2020
64
5.060
Why?
Calcitriol
18
2020
25
4.980
Why?
Immunologic Factors
22
2021
49
4.860
Why?
Practice Guidelines as Topic
32
2020
410
4.800
Why?
Clinical Trials as Topic
39
2019
316
4.600
Why?
Benzoyl Peroxide
16
2021
19
4.570
Why?
Keratolytic Agents
24
2018
29
4.460
Why?
Drug Costs
22
2020
47
4.340
Why?
Keratosis, Actinic
11
2021
20
4.220
Why?
Acitretin
17
2018
18
4.140
Why?
Arthritis, Psoriatic
20
2019
25
4.140
Why?
Dermatitis, Allergic Contact
10
2019
15
4.100
Why?
Child
85
2020
2472
3.920
Why?
Aged
134
2021
10398
3.910
Why?
Drug Prescriptions
17
2017
54
3.830
Why?
Health Expenditures
11
2020
66
3.700
Why?
Internship and Residency
12
2019
306
3.460
Why?
Betamethasone
12
2020
53
3.440
Why?
Internet
17
2019
203
3.310
Why?
Retrospective Studies
67
2020
3514
3.280
Why?
Erythema
11
2019
27
3.260
Why?
Cost-Benefit Analysis
38
2018
187
3.160
Why?
Nicotinic Acids
7
2020
8
3.110
Why?
Depression
17
2021
436
3.010
Why?
Drug Monitoring
14
2019
26
2.890
Why?
Ultraviolet Rays
16
2020
50
2.850
Why?
Boron Compounds
6
2020
11
2.810
Why?
Randomized Controlled Trials as Topic
28
2021
511
2.800
Why?
Pruritus
14
2020
64
2.800
Why?
Drug Therapy, Combination
33
2019
301
2.800
Why?
Biological Factors
7
2020
11
2.780
Why?
Drug Utilization
15
2018
49
2.680
Why?
Facial Dermatoses
9
2019
18
2.680
Why?
Thalidomide
7
2019
31
2.680
Why?
Immunoglobulin G
20
2013
121
2.670
Why?
Cost of Illness
17
2020
70
2.640
Why?
Insurance, Health
12
2020
97
2.590
Why?
Patient Acceptance of Health Care
11
2020
171
2.590
Why?
Communication
11
2019
140
2.550
Why?
Patient Preference
13
2019
48
2.540
Why?
Naphthalenes
8
2021
40
2.510
Why?
Home Care Services
7
2020
53
2.500
Why?
Tumor Necrosis Factor-alpha
14
2019
213
2.480
Why?
Administration, Oral
25
2019
185
2.460
Why?
Self Care
10
2019
145
2.440
Why?
Prevalence
38
2021
986
2.370
Why?
Child, Preschool
44
2020
1281
2.370
Why?
Databases, Factual
25
2020
355
2.360
Why?
Comorbidity
23
2020
572
2.360
Why?
Prescription Drugs
6
2020
20
2.320
Why?
Biological Therapy
9
2020
22
2.280
Why?
Double-Blind Method
27
2021
550
2.280
Why?
Scalp Dermatoses
6
2016
18
2.240
Why?
Sunbathing
5
2018
6
2.240
Why?
Receptors, Tumor Necrosis Factor
20
2013
49
2.200
Why?
Quality of Health Care
9
2018
151
2.150
Why?
Drug Administration Schedule
27
2019
279
2.110
Why?
Ambulatory Surgical Procedures
12
2013
27
2.080
Why?
Antirheumatic Agents
12
2020
30
2.080
Why?
Oxymetazoline
4
2019
4
2.040
Why?
PUVA Therapy
19
2017
22
2.030
Why?
Publishing
4
2020
63
2.000
Why?
Drug Design
8
2020
47
1.960
Why?
Anti-Infective Agents
7
2017
43
1.950
Why?
Interleukin-17
5
2019
27
1.910
Why?
Tretinoin
8
2014
34
1.890
Why?
Biopsy
8
2019
273
1.880
Why?
Eczema
7
2020
13
1.860
Why?
Drug Combinations
17
2021
93
1.850
Why?
Hand Dermatoses
6
2010
10
1.810
Why?
Age Factors
31
2020
1204
1.800
Why?
Pyrroles
8
2018
57
1.790
Why?
Agricultural Workers' Diseases
15
2013
85
1.770
Why?
Risk Assessment
27
2019
1447
1.770
Why?
Pyrimidines
8
2018
65
1.770
Why?
Metronidazole
8
2017
15
1.770
Why?
Inflammatory Bowel Diseases
3
2018
29
1.720
Why?
Sunscreening Agents
6
2020
13
1.710
Why?
Medicare
19
2020
206
1.690
Why?
Lymphoma
5
2018
35
1.650
Why?
Anti-Inflammatory Agents, Non-Steroidal
5
2019
77
1.640
Why?
Isotretinoin
7
2014
12
1.610
Why?
Periodicals as Topic
5
2020
101
1.600
Why?
Time Factors
27
2020
2181
1.590
Why?
Aged, 80 and over
37
2020
4050
1.580
Why?
Skin Care
5
2019
13
1.570
Why?
Evidence-Based Medicine
18
2021
217
1.550
Why?
Fluorouracil
4
2020
82
1.550
Why?
Pain
10
2020
305
1.550
Why?
Bibliometrics
3
2020
12
1.520
Why?
Pediatrics
9
2020
158
1.510
Why?
Drug Industry
5
2019
17
1.510
Why?
Cosmetic Techniques
4
2018
11
1.500
Why?
Pyoderma Gangrenosum
4
2017
12
1.500
Why?
Physician's Role
6
2017
41
1.490
Why?
Carcinoma, Basal Cell
10
2015
26
1.490
Why?
Cyclosporine
11
2020
49
1.460
Why?
Infant
28
2020
1076
1.440
Why?
Piperidines
8
2018
125
1.420
Why?
Tacrolimus
8
2018
64
1.400
Why?
Caregivers
6
2019
112
1.400
Why?
Goals
2
2020
37
1.390
Why?
Gels
11
2017
32
1.390
Why?
Mohs Surgery
9
2020
16
1.380
Why?
Sex Factors
21
2020
674
1.380
Why?
Tuberculosis
5
2020
15
1.370
Why?
Small Molecule Libraries
3
2017
11
1.370
Why?
Interleukin-23 Subunit p19
2
2019
11
1.350
Why?
Hyperlipidemias
3
2018
54
1.340
Why?
Fingers
3
2019
64
1.340
Why?
Patient Selection
9
2015
289
1.340
Why?
Recombinant Fusion Proteins
10
2013
103
1.340
Why?
Registries
8
2021
300
1.340
Why?
Triamcinolone
5
2018
13
1.330
Why?
Ethnic Groups
8
2020
480
1.330
Why?
Clindamycin
4
2014
21
1.320
Why?
Salicylic Acid
5
2013
6
1.300
Why?
Wound Healing
7
2018
194
1.280
Why?
Cross-Sectional Studies
28
2020
1522
1.270
Why?
Health Resources
3
2018
33
1.260
Why?
Dermatitis
9
2019
21
1.250
Why?
Arthritis, Rheumatoid
3
2018
40
1.250
Why?
Drug Packaging
3
2020
5
1.250
Why?
Behavior, Addictive
4
2009
32
1.250
Why?
Lasers, Excimer
4
2012
8
1.240
Why?
Delivery of Health Care
8
2017
161
1.240
Why?
Carcinoma, Squamous Cell
9
2015
154
1.220
Why?
Vitamin D
8
2020
186
1.210
Why?
Animals
27
2020
7694
1.210
Why?
Foot Dermatoses
5
2009
9
1.190
Why?
Keratosis
7
2016
23
1.190
Why?
Primary Health Care
6
2017
221
1.170
Why?
Doxycycline
4
2017
25
1.160
Why?
Dermatitis, Contact
6
2014
11
1.160
Why?
Physicians
9
2018
161
1.150
Why?
Antifungal Agents
5
2015
39
1.150
Why?
Transients and Migrants
17
2013
293
1.150
Why?
Dose-Response Relationship, Drug
16
2019
675
1.150
Why?
Attitude of Health Personnel
5
2014
182
1.140
Why?
Hypothyroidism
2
2016
13
1.130
Why?
Patient Care Planning
3
2020
58
1.130
Why?
Biomedical Research
4
2019
169
1.110
Why?
Melanoma
8
2017
165
1.110
Why?
Dermatitis, Occupational
5
2019
10
1.100
Why?
Reminder Systems
2
2018
22
1.100
Why?
Coronavirus Infections
4
2020
113
1.100
Why?
Pneumonia, Viral
4
2020
118
1.090
Why?
Medicine
7
2020
39
1.090
Why?
Ointments
13
2020
24
1.080
Why?
Melanosis
7
2010
15
1.070
Why?
Models, Economic
8
2018
20
1.060
Why?
Emollients
8
2017
11
1.050
Why?
Fluocinonide
5
2019
11
1.050
Why?
Onychomycosis
4
2019
8
1.040
Why?
Ivermectin
4
2018
9
1.040
Why?
Insurance Coverage
7
2017
75
1.030
Why?
Dicarboxylic Acids
4
2017
10
1.020
Why?
Cardiovascular Diseases
8
2018
1133
1.020
Why?
Hyperpigmentation
4
2018
17
1.020
Why?
Health Knowledge, Attitudes, Practice
6
2017
353
1.010
Why?
Protein Kinase Inhibitors
6
2018
85
1.010
Why?
Contraceptives, Oral, Combined
2
2017
6
1.010
Why?
Beauty Culture
5
2009
7
1.010
Why?
Drug Compounding
8
2019
37
1.000
Why?
Managed Care Programs
8
2014
41
1.000
Why?
Hispanic Americans
21
2014
949
0.990
Why?
Hospitalization
11
2020
465
0.990
Why?
Photography
4
2020
41
0.990
Why?
Prednisone
4
2012
62
0.980
Why?
Telemedicine
4
2021
99
0.980
Why?
Specialties, Surgical
3
2013
27
0.970
Why?
Scalp
5
2020
38
0.970
Why?
Placebo Effect
4
2017
15
0.970
Why?
Off-Label Use
6
2020
12
0.960
Why?
Tetracycline
4
2014
12
0.960
Why?
Utilization Review
2
2019
17
0.960
Why?
Cicatrix
3
2015
38
0.960
Why?
Treatment Refusal
4
2007
11
0.950
Why?
Hot Temperature
5
2014
79
0.950
Why?
Nonprescription Drugs
5
2015
21
0.950
Why?
Clinical Trials, Phase III as Topic
7
2020
28
0.940
Why?
Allergens
2
2019
18
0.940
Why?
Depressive Disorder
3
2018
76
0.940
Why?
Combined Modality Therapy
15
2019
567
0.940
Why?
Continental Population Groups
4
2020
239
0.940
Why?
Health Services Accessibility
5
2017
242
0.940
Why?
Health Promotion
3
2018
242
0.940
Why?
Pharmaceutical Preparations
2
2019
37
0.930
Why?
Risk
4
2018
325
0.920
Why?
Medicaid
9
2020
95
0.920
Why?
Interleukin-23
4
2019
22
0.910
Why?
Transcutaneous Electric Nerve Stimulation
2
2019
9
0.910
Why?
Pathology
3
2009
19
0.900
Why?
Vasoconstriction
4
2017
41
0.900
Why?
Risk Factors
26
2021
3876
0.890
Why?
Follow-Up Studies
20
2018
2296
0.890
Why?
Reimbursement, Incentive
2
2015
11
0.890
Why?
Disease Management
5
2018
131
0.890
Why?
Monitoring, Physiologic
3
2020
77
0.880
Why?
Cost Control
3
2020
18
0.880
Why?
Azetidines
2
2020
10
0.880
Why?
Dermoscopy
2
2013
12
0.880
Why?
Attitude to Health
6
2019
167
0.870
Why?
Laser Therapy
7
2019
55
0.870
Why?
Burns
2
2014
102
0.870
Why?
Counseling
3
2020
99
0.870
Why?
Sickness Impact Profile
9
2015
37
0.860
Why?
Video Recording
2
2013
57
0.860
Why?
Tetracyclines
2
2019
2
0.850
Why?
Sulfonamides
2
2020
67
0.850
Why?
Vitiligo
3
2019
4
0.840
Why?
Research Design
7
2015
313
0.840
Why?
Surgery, Plastic
5
2013
27
0.830
Why?
Quality Assurance, Health Care
3
2009
74
0.830
Why?
Ethics, Medical
2
2020
21
0.830
Why?
Drugs, Generic
5
2020
15
0.820
Why?
Vasoconstrictor Agents
2
2019
62
0.810
Why?
Hypertension
3
2018
972
0.810
Why?
Treatment Failure
8
2018
171
0.810
Why?
Equipment and Supplies
2
2020
16
0.800
Why?
Guidelines as Topic
2
2020
48
0.800
Why?
Autoimmune Diseases
3
2018
49
0.800
Why?
Petrolatum
2
2020
4
0.800
Why?
Prescription Fees
2
2016
6
0.800
Why?
Adolescent Behavior
2
2020
61
0.800
Why?
Cryosurgery
4
2015
21
0.790
Why?
United States Food and Drug Administration
7
2019
48
0.790
Why?
Education, Distance
1
2021
18
0.780
Why?
Pilot Projects
11
2018
536
0.770
Why?
Budgets
2
2018
10
0.770
Why?
Obesity
9
2018
1164
0.770
Why?
Surgical Procedures, Operative
5
2010
83
0.760
Why?
Self Concept
5
2015
42
0.760
Why?
Clinical Clerkship
1
2021
42
0.760
Why?
Therapies, Investigational
1
2020
4
0.760
Why?
Antiviral Agents
3
2020
110
0.760
Why?
Adrenergic alpha-Agonists
2
2017
42
0.760
Why?
Tattooing
2
2011
7
0.760
Why?
Inflammation
4
2019
542
0.750
Why?
Specialization
6
2017
32
0.750
Why?
Plant Extracts
2
2018
61
0.750
Why?
Anti-Infective Agents, Local
2
2020
15
0.740
Why?
Forehead
1
2020
13
0.740
Why?
Sleep
2
2013
93
0.740
Why?
Aerosols
2
2020
14
0.740
Why?
Phobic Disorders
1
2020
9
0.740
Why?
Incidence
13
2021
1207
0.740
Why?
Gentian Violet
1
2020
3
0.730
Why?
Immunotherapy
2
2018
83
0.730
Why?
Professional Practice
3
2011
24
0.730
Why?
Medication Errors
4
2009
22
0.730
Why?
Warts
1
2020
3
0.720
Why?
Injections, Intralesional
1
2020
15
0.720
Why?
Back
1
2020
4
0.720
Why?
Social Conformity
1
2020
1
0.720
Why?
Baths
1
2020
8
0.720
Why?
Cultural Diversity
1
2020
22
0.710
Why?
Drug Delivery Systems
3
2020
101
0.710
Why?
Impetigo
2
2012
4
0.710
Why?
Affect
3
2011
69
0.710
Why?
Infant, Newborn
13
2020
681
0.700
Why?
Balsams
1
2019
1
0.700
Why?
Electrical Equipment and Supplies
1
2019
1
0.700
Why?
Job Application
1
2019
6
0.700
Why?
Pigmentation Disorders
3
2014
8
0.700
Why?
Books
1
2019
3
0.700
Why?
Alcoholic Beverages
1
2019
6
0.700
Why?
North Carolina
23
2017
1520
0.700
Why?
Neuralgia, Postherpetic
1
2019
6
0.700
Why?
Safety Management
3
2010
36
0.700
Why?
Cost Savings
5
2013
34
0.700
Why?
Patient Care
3
2017
37
0.690
Why?
Leg Dermatoses
1
2019
2
0.690
Why?
Multivariate Analysis
14
2015
696
0.690
Why?
Skin Diseases, Genetic
1
2019
4
0.690
Why?
Self Administration
3
2010
303
0.680
Why?
Patients
5
2013
47
0.670
Why?
Bonding, Human-Pet
1
2019
1
0.670
Why?
Veterinarians
1
2019
1
0.670
Why?
Animal Husbandry
1
2019
7
0.670
Why?
Injections, Subcutaneous
6
2019
38
0.670
Why?
Perception
5
2018
98
0.670
Why?
Finger Joint
1
2019
12
0.660
Why?
Skin Aging
1
2019
8
0.660
Why?
Fish Oils
1
2019
35
0.660
Why?
Family Practice
6
2015
51
0.660
Why?
Electrocoagulation
2
2016
12
0.660
Why?
Morgellons Disease
1
2018
3
0.660
Why?
Wound Infection
1
2018
12
0.660
Why?
Fees and Charges
2
2016
14
0.660
Why?
Whole-Body Irradiation
1
2019
50
0.660
Why?
Aortitis
1
2018
1
0.660
Why?
Pharmacogenetics
1
2018
36
0.660
Why?
Economics, Pharmaceutical
4
2017
5
0.650
Why?
Income
2
2021
60
0.650
Why?
Benchmarking
4
2012
26
0.650
Why?
Chronic Disease
12
2017
406
0.650
Why?
Antiretroviral Therapy, Highly Active
1
2018
29
0.650
Why?
Hepatitis B
1
2018
17
0.650
Why?
Central Nervous System Neoplasms
1
2019
29
0.650
Why?
Antipsychotic Agents
1
2018
28
0.650
Why?
Patient-Centered Care
2
2012
74
0.650
Why?
Adaptation, Psychological
2
2017
134
0.640
Why?
Public Opinion
2
2018
19
0.640
Why?
Sick Leave
1
2018
4
0.640
Why?
Health Insurance Portability and Accountability Act
1
2018
5
0.640
Why?
Education, Medical, Graduate
3
2015
126
0.640
Why?
Prescriptions
3
2015
12
0.640
Why?
Thyroid Neoplasms
1
2019
31
0.640
Why?
Emergency Service, Hospital
3
2016
463
0.630
Why?
Nails, Ingrown
2
2015
2
0.630
Why?
Blood Donors
1
2018
13
0.630
Why?
Tinea
2
2016
4
0.630
Why?
Cytokines
2
2017
262
0.630
Why?
Confidentiality
1
2018
30
0.630
Why?
Porphyrins
1
2018
29
0.630
Why?
Injections
5
2019
65
0.630
Why?
Porphyria Cutanea Tarda
1
2018
15
0.620
Why?
Health Services
2
2017
39
0.620
Why?
Candidiasis, Chronic Mucocutaneous
1
2017
1
0.620
Why?
Donor Selection
1
2018
33
0.620
Why?
International Cooperation
2
2020
28
0.620
Why?
Range of Motion, Articular
1
2019
187
0.620
Why?
Efficiency
4
2019
18
0.620
Why?
Caloric Restriction
1
2019
96
0.610
Why?
Drug Resistance
4
2018
42
0.610
Why?
Logistic Models
10
2015
788
0.610
Why?
Janus Kinases
3
2016
4
0.600
Why?
Alopecia Areata
2
2015
16
0.600
Why?
Academic Medical Centers
5
2019
160
0.600
Why?
Faculty, Medical
2
2010
78
0.600
Why?
Drug Approval
4
2019
10
0.590
Why?
Glioma
1
2019
136
0.590
Why?
Medical Errors
2
2010
38
0.590
Why?
Nevus
2
2015
15
0.590
Why?
Health Behavior
3
2015
229
0.590
Why?
Photochemotherapy
2
2017
21
0.590
Why?
Agriculture
7
2013
186
0.590
Why?
Alcohol Drinking
2
2017
257
0.590
Why?
Receptors, Interleukin
1
2017
16
0.590
Why?
Staphylococcus aureus
2
2019
46
0.590
Why?
Liver Neoplasms
1
2019
159
0.580
Why?
Residence Characteristics
2
2017
190
0.580
Why?
Facial Neoplasms
2
2008
9
0.580
Why?
Professional-Patient Relations
1
2017
26
0.580
Why?
Sunlight
6
2019
17
0.580
Why?
Parents
3
2020
150
0.570
Why?
Electrodes
2
2016
19
0.570
Why?
Cellulitis
1
2016
11
0.570
Why?
Cohort Studies
9
2018
1832
0.570
Why?
Abscess
1
2016
26
0.570
Why?
Exanthema
1
2016
21
0.570
Why?
Outpatients
6
2016
58
0.560
Why?
Online Systems
1
2016
13
0.560
Why?
Software
2
2017
126
0.560
Why?
Pyrazoles
2
2017
68
0.560
Why?
Zebrafish
1
2016
23
0.560
Why?
Diagnostic Errors
1
2016
46
0.560
Why?
Reproducibility of Results
11
2020
779
0.560
Why?
Biomimetic Materials
1
2016
16
0.560
Why?
Biopsy, Needle
2
2018
98
0.550
Why?
Health Care Rationing
2
2014
14
0.550
Why?
Electrosurgery
3
2014
5
0.550
Why?
Accidents, Traffic
1
2018
195
0.550
Why?
Skin Pigmentation
5
2014
25
0.550
Why?
Interpersonal Relations
4
2017
56
0.540
Why?
Cryotherapy
3
2012
13
0.540
Why?
Abnormalities, Drug-Induced
2
2006
5
0.540
Why?
Medical Records
4
2013
77
0.540
Why?
Hydroquinones
4
2014
6
0.540
Why?
African Americans
8
2017
1443
0.530
Why?
Naltrexone
2
2006
42
0.520
Why?
Empathy
2
2013
19
0.520
Why?
Mothers
2
2013
87
0.520
Why?
Body Surface Area
3
2017
15
0.520
Why?
Spondylitis, Ankylosing
1
2015
4
0.520
Why?
Occupational Diseases
6
2014
81
0.510
Why?
Teratoma
1
2015
10
0.510
Why?
Fee-for-Service Plans
1
2015
12
0.510
Why?
Etretinate
2
2013
2
0.510
Why?
Costs and Cost Analysis
5
2016
100
0.510
Why?
European Continental Ancestry Group
9
2017
1180
0.510
Why?
Precancerous Conditions
3
2011
27
0.500
Why?
Diagnosis, Differential
7
2018
525
0.500
Why?
Needs Assessment
3
2014
78
0.500
Why?
Disease Models, Animal
2
2016
1040
0.500
Why?
Urocanic Acid
1
2014
1
0.500
Why?
Physical Examination
3
2015
94
0.500
Why?
Splints
1
2014
13
0.500
Why?
Lipoxins
1
2014
2
0.500
Why?
Acrylates
1
2014
1
0.500
Why?
Onycholysis
1
2014
1
0.500
Why?
Age Distribution
6
2020
210
0.500
Why?
Clinical Trials, Phase II as Topic
3
2020
17
0.500
Why?
Arthritis
1
2015
40
0.490
Why?
Electronic Mail
2
2017
18
0.490
Why?
Social Desirability
1
2014
12
0.490
Why?
Parathyroid Neoplasms
1
2014
7
0.490
Why?
Medically Underserved Area
3
2013
23
0.490
Why?
Single-Blind Method
4
2020
200
0.490
Why?
Antihypertensive Agents
1
2017
362
0.490
Why?
Surgical Wound Infection
2
2014
90
0.490
Why?
Antitubercular Agents
1
2014
7
0.480
Why?
Electronic Health Records
5
2018
158
0.480
Why?
Isoniazid
1
2014
3
0.480
Why?
Lupus Erythematosus, Discoid
1
2014
7
0.480
Why?
Quality Indicators, Health Care
3
2015
62
0.480
Why?
Self Medication
2
2011
6
0.480
Why?
Excipients
1
2014
2
0.480
Why?
Erythromycin
1
2014
7
0.480
Why?
Rural Health Services
3
2009
30
0.480
Why?
Home Nursing
3
2010
10
0.480
Why?
Adenoma
1
2014
39
0.480
Why?
Anxiety
7
2021
185
0.470
Why?
Contraceptives, Oral
2
2012
22
0.470
Why?
Gynecomastia
1
2014
2
0.470
Why?
Head and Neck Neoplasms
3
2015
129
0.470
Why?
Webcasts as Topic
2
2012
3
0.470
Why?
Scurvy
1
2013
3
0.470
Why?
Case-Control Studies
6
2020
911
0.470
Why?
Hidradenitis Suppurativa
3
2019
9
0.460
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2014
44
0.460
Why?
Flutamide
1
2013
6
0.460
Why?
Hydroxy Acids
1
2013
2
0.460
Why?
Lupus Erythematosus, Systemic
2
2014
148
0.460
Why?
HIV Infections
1
2018
388
0.460
Why?
Folic Acid Deficiency
1
2013
2
0.450
Why?
Antineoplastic Agents, Hormonal
1
2013
40
0.450
Why?
Folic Acid Antagonists
1
2013
3
0.450
Why?
Herpes Labialis
1
2013
1
0.450
Why?
Drug Eruptions
1
2013
9
0.450
Why?
Transportation
1
2013
13
0.450
Why?
Folic Acid
1
2013
13
0.450
Why?
Breast
1
2014
61
0.450
Why?
Drug Tolerance
1
2013
35
0.450
Why?
Consensus
4
2020
83
0.450
Why?
Clinical Competence
5
2015
331
0.450
Why?
Dermatomycoses
3
2009
7
0.450
Why?
Physician Assistants
3
2010
42
0.450
Why?
Socioeconomic Factors
6
2018
422
0.450
Why?
Vitamin D Deficiency
1
2014
93
0.440
Why?
Health Surveys
8
2019
202
0.440
Why?
Nevus, Sebaceous of Jadassohn
1
2012
1
0.440
Why?
Mouth
1
2013
25
0.440
Why?
Signal Processing, Computer-Assisted
1
2013
46
0.430
Why?
Staphylococcal Skin Infections
1
2012
4
0.430
Why?
Health Services Research
3
2010
82
0.430
Why?
Disease Progression
4
2018
618
0.430
Why?
Patch Tests
4
2010
8
0.430
Why?
Progestins
1
2012
21
0.420
Why?
Decision Making
2
2019
205
0.420
Why?
Telephone
4
2018
59
0.420
Why?
Hydrocortisone
2
2011
61
0.420
Why?
Employment
2
2018
49
0.420
Why?
Antimetabolites
1
2012
11
0.420
Why?
Cosmetics
3
2010
11
0.420
Why?
Arthrodermataceae
2
2009
3
0.410
Why?
Imaging, Three-Dimensional
1
2013
133
0.410
Why?
Organ Transplantation
1
2012
69
0.410
Why?
Drug Resistance, Bacterial
5
2014
42
0.400
Why?
Data Collection
6
2014
185
0.400
Why?
Practice Management, Medical
2
2013
8
0.400
Why?
Fluocinolone Acetonide
2
2012
7
0.400
Why?
Choice Behavior
3
2019
86
0.400
Why?
Demyelinating Diseases
1
2011
10
0.400
Why?
Self-Examination
1
2011
1
0.400
Why?
Self Efficacy
3
2017
78
0.400
Why?
Propionibacterium acnes
4
2014
4
0.390
Why?
Health Status
3
2011
402
0.390
Why?
Pityriasis Rubra Pilaris
1
2011
1
0.390
Why?
Information Dissemination
2
2009
51
0.390
Why?
Foundations
2
2008
8
0.390
Why?
Image Processing, Computer-Assisted
1
2013
244
0.390
Why?
Regression Analysis
6
2017
296
0.390
Why?
Molluscum Contagiosum
2
2015
3
0.390
Why?
Appointments and Schedules
2
2020
21
0.390
Why?
Estrogens
1
2012
174
0.390
Why?
Zinc
2
2019
32
0.380
Why?
Computer Peripherals
1
2010
1
0.380
Why?
Friction
1
2010
4
0.380
Why?
Diet
1
2013
384
0.380
Why?
Odds Ratio
6
2017
480
0.380
Why?
Photosensitizing Agents
3
2010
23
0.380
Why?
Clotrimazole
3
2007
4
0.380
Why?
Educational Status
4
2020
177
0.380
Why?
Eyeglasses
1
2010
3
0.380
Why?
Antidepressive Agents
2
2014
77
0.370
Why?
Chromium
1
2010
1
0.370
Why?
Nickel
1
2010
2
0.370
Why?
Linear Models
4
2019
454
0.370
Why?
Risk-Taking
2
2009
97
0.370
Why?
Health Services Misuse
1
2010
7
0.370
Why?
Frozen Sections
1
2010
18
0.370
Why?
Desonide
1
2010
1
0.370
Why?
Pharmaceutical Services
1
2010
6
0.370
Why?
Pregnancy
9
2019
1010
0.370
Why?
Life Style
1
2013
404
0.360
Why?
Vitamin E
1
2010
23
0.360
Why?
Prospective Studies
7
2018
2274
0.360
Why?
Publications
1
2010
9
0.360
Why?
Ear Cartilage
1
2010
12
0.360
Why?
Patient Participation
2
2014
81
0.360
Why?
Algorithms
6
2015
497
0.360
Why?
Medically Uninsured
1
2010
32
0.360
Why?
Antimetabolites, Antineoplastic
2
2014
49
0.360
Why?
Textiles
1
2009
1
0.360
Why?
Clothing
1
2009
5
0.360
Why?
Social Marketing
1
2010
15
0.350
Why?
Cartilage Diseases
1
2010
21
0.350
Why?
Financing, Personal
2
2014
6
0.350
Why?
Marketing
1
2010
24
0.350
Why?
Communicable Diseases
1
2009
21
0.350
Why?
Health Care Reform
1
2010
43
0.340
Why?
Cost Sharing
2
2006
10
0.340
Why?
Data Interpretation, Statistical
2
2013
110
0.340
Why?
Mandatory Reporting
3
2006
7
0.340
Why?
Dermatitis, Perioral
1
2009
1
0.340
Why?
Education, Medical
1
2010
70
0.340
Why?
Burnout, Professional
2
2021
50
0.340
Why?
General Surgery
3
2014
85
0.340
Why?
Risk Management
2
2006
29
0.340
Why?
Insurance Carriers
1
2009
18
0.340
Why?
Neoplasms
3
2017
695
0.340
Why?
Elastic Tissue
1
2009
2
0.330
Why?
Triage
2
2010
72
0.330
Why?
Radio Waves
1
2009
8
0.330
Why?
Physicians' Offices
3
2005
10
0.330
Why?
Narcotic Antagonists
2
2006
59
0.330
Why?
Sirolimus
1
2009
34
0.330
Why?
Pamphlets
2
2007
5
0.330
Why?
Social Support
3
2017
180
0.320
Why?
Language
3
2007
45
0.320
Why?
Placebos
3
2020
66
0.320
Why?
Mass Screening
3
2017
263
0.320
Why?
Fibromyalgia
1
2009
25
0.320
Why?
Fluocortolone
1
2008
1
0.320
Why?
Diabetes Mellitus, Type 2
1
2017
1428
0.320
Why?
Interleukin-12
2
2008
30
0.320
Why?
Guideline Adherence
3
2015
122
0.320
Why?
Internal Medicine
4
2015
54
0.320
Why?
Multicenter Studies as Topic
3
2019
102
0.310
Why?
Hand
2
2019
67
0.310
Why?
Crohn Disease
2
2019
26
0.310
Why?
Selection Bias
1
2008
14
0.310
Why?
Colitis, Ulcerative
2
2018
22
0.310
Why?
Safety
5
2011
78
0.310
Why?
Healthcare Disparities
1
2010
166
0.310
Why?
Histamine Antagonists
3
2018
5
0.310
Why?
Occupational Exposure
5
2009
238
0.310
Why?
Social Problems
1
2007
2
0.310
Why?
Interleukin-12 Subunit p40
1
2007
3
0.300
Why?
Internationality
1
2007
22
0.300
Why?
Quality-Adjusted Life Years
3
2017
30
0.300
Why?
Interviews as Topic
6
2017
263
0.300
Why?
Asian Continental Ancestry Group
3
2014
111
0.300
Why?
Episode of Care
2
2004
5
0.300
Why?
Sexually Transmitted Diseases
1
2008
42
0.300
Why?
Substance-Related Disorders
1
2008
124
0.290
Why?
Pregnancy Outcome
2
2018
91
0.290
Why?
Interleukins
2
2017
17
0.290
Why?
Absenteeism
3
2018
11
0.290
Why?
Skin Diseases, Vesiculobullous
1
2007
6
0.290
Why?
Career Choice
1
2007
41
0.290
Why?
Sleep Apnea Syndromes
2
2017
30
0.280
Why?
Forms and Records Control
1
2006
7
0.280
Why?
Fellowships and Scholarships
1
2007
53
0.280
Why?
Personality
3
2014
16
0.280
Why?
Electronics
1
2006
14
0.280
Why?
Tachyphylaxis
1
2006
1
0.280
Why?
beta-Endorphin
1
2006
2
0.280
Why?
Multiple Sclerosis
1
2007
61
0.270
Why?
Women
1
2006
11
0.270
Why?
Evaluation Studies as Topic
2
2016
48
0.270
Why?
Seasons
4
2017
86
0.270
Why?
Surgicenters
2
2004
3
0.270
Why?
Anti-Allergic Agents
2
2017
7
0.260
Why?
Reconstructive Surgical Procedures
2
2007
199
0.260
Why?
Health Services for the Aged
2
2007
28
0.260
Why?
Carcinoma
1
2006
93
0.260
Why?
Europe
3
2015
83
0.260
Why?
Insurance Benefits
1
2005
5
0.260
Why?
Acne Keloid
1
2005
2
0.260
Why?
Social Behavior
1
2006
65
0.260
Why?
Insurance Claim Review
2
2019
28
0.260
Why?
Withholding Treatment
2
2018
12
0.260
Why?
Narcotics
1
2005
19
0.260
Why?
Heliotherapy
1
2005
3
0.250
Why?
Complementary Therapies
2
2017
79
0.250
Why?
Sensitivity and Specificity
3
2013
600
0.250
Why?
Hospital Charges
1
2005
15
0.250
Why?
Tinea Pedis
2
2015
5
0.250
Why?
Relaxation
2
2019
9
0.250
Why?
Rheumatology
3
2020
9
0.250
Why?
Fear
2
2019
46
0.250
Why?
Sex Distribution
3
2017
201
0.250
Why?
Automobiles
2
2014
15
0.240
Why?
Dietary Supplements
2
2019
184
0.240
Why?
Age of Onset
3
2020
100
0.240
Why?
Lupus Erythematosus, Cutaneous
2
2018
13
0.240
Why?
Bioterrorism
1
2003
6
0.230
Why?
Meat-Packing Industry
2
2014
8
0.230
Why?
Early Diagnosis
2
2017
64
0.230
Why?
Itraconazole
1
2003
6
0.230
Why?
Iran
2
2013
4
0.230
Why?
Organometallic Compounds
1
2003
25
0.230
Why?
Disclosure
1
2003
39
0.230
Why?
Insurance Claim Reporting
1
2003
3
0.220
Why?
Current Procedural Terminology
1
2003
4
0.220
Why?
Program Development
2
2018
97
0.220
Why?
Pyridines
1
2003
81
0.220
Why?
Tonsillitis
1
2003
5
0.220
Why?
Referral and Consultation
3
2011
140
0.220
Why?
Occupational Health
3
2015
82
0.220
Why?
Prognosis
6
2019
1523
0.220
Why?
Directive Counseling
1
2002
18
0.220
Why?
Qualitative Research
3
2018
159
0.220
Why?
Pregnancy Complications
2
2009
107
0.220
Why?
T-Lymphocytes
2
2014
128
0.220
Why?
Aminoquinolines
2
2015
16
0.210
Why?
Demography
2
2020
109
0.210
Why?
Analysis of Variance
4
2020
470
0.210
Why?
Nausea
1
2002
54
0.210
Why?
Drugs, Investigational
2
2020
7
0.210
Why?
Staphylococcal Infections
1
2003
63
0.210
Why?
Diabetes Mellitus
3
2015
410
0.210
Why?
Hypnotics and Sedatives
1
2002
29
0.210
Why?
Food-Processing Industry
3
2013
40
0.200
Why?
Drug Administration Routes
3
2012
12
0.200
Why?
Equipment Design
3
2014
172
0.200
Why?
Mice, Knockout
2
2017
449
0.200
Why?
Emigrants and Immigrants
3
2014
250
0.200
Why?
Dosage Forms
2
2012
4
0.190
Why?
Solutions
2
2016
36
0.190
Why?
Diterpenes
1
2021
20
0.190
Why?
Psychometrics
4
2015
137
0.190
Why?
Models, Econometric
2
2017
8
0.190
Why?
History, 21st Century
2
2020
61
0.190
Why?
Mental Disorders
1
2002
119
0.190
Why?
History, 20th Century
2
2020
76
0.190
Why?
Organizations, Nonprofit
1
2020
6
0.190
Why?
Liver
2
2016
486
0.190
Why?
Mice
4
2017
2524
0.190
Why?
Societies, Medical
3
2019
165
0.180
Why?
Postoperative Care
2
2018
78
0.180
Why?
Lichen Sclerosus et Atrophicus
1
2020
9
0.180
Why?
Employee Retirement Income Security Act
1
2020
5
0.180
Why?
Face
2
2017
30
0.180
Why?
Tuberculin
1
2020
1
0.180
Why?
Pharmacy
1
2020
2
0.180
Why?
Education, Medical, Undergraduate
1
2021
88
0.180
Why?
Republic of Korea
1
2020
12
0.180
Why?
Aminolevulinic Acid
1
2020
9
0.180
Why?
Japan
1
2020
17
0.180
Why?
Steroids
1
2020
38
0.180
Why?
Mycobacterium
1
2020
3
0.180
Why?
Bacterial Vaccines
1
2020
8
0.180
Why?
Interdisciplinary Communication
2
2013
58
0.180
Why?
Pain Measurement
3
2018
370
0.180
Why?
Communicable Disease Control
1
2020
15
0.180
Why?
BCG Vaccine
1
2020
8
0.180
Why?
Journal Impact Factor
1
2020
11
0.180
Why?
China
1
2020
50
0.180
Why?
Drug Synergism
1
2020
71
0.180
Why?
Blood Cell Count
1
2020
28
0.180
Why?
Sampling Studies
3
2009
43
0.180
Why?
Informed Consent
1
2020
56
0.180
Why?
Early Detection of Cancer
2
2019
87
0.180
Why?
Neurodermatitis
1
2019
3
0.180
Why?
Metabolome
1
2020
36
0.180
Why?
Interferon-alpha
1
2020
71
0.180
Why?
Congresses as Topic
2
2012
39
0.170
Why?
Ficusin
3
2010
5
0.170
Why?
Thorax
1
2019
29
0.170
Why?
Authorship
1
2019
9
0.170
Why?
Unnecessary Procedures
1
2019
16
0.170
Why?
Statistics, Nonparametric
2
2010
133
0.170
Why?
Students, Medical
1
2021
131
0.170
Why?
Clinical Protocols
2
2011
100
0.170
Why?
Random Allocation
1
2020
220
0.170
Why?
Women's Health
1
2021
235
0.170
Why?
Patient Care Team
2
2010
131
0.170
Why?
Arm
1
2019
36
0.170
Why?
Herpes Zoster Vaccine
1
2019
4
0.170
Why?
Diet, Gluten-Free
1
2019
3
0.170
Why?
Selenium
1
2019
4
0.170
Why?
Malassezia
1
2019
1
0.170
Why?
Work Schedule Tolerance
1
2019
10
0.170
Why?
Herpes Zoster
1
2019
10
0.170
Why?
Periodontitis
1
2019
9
0.170
Why?
Croton
1
2018
2
0.170
Why?
Hyperhidrosis
1
2019
5
0.170
Why?
Candida albicans
1
2019
12
0.170
Why?
Paternal Exposure
1
2018
1
0.170
Why?
Streptococcus pyogenes
1
2019
16
0.170
Why?
Probiotics
1
2019
10
0.170
Why?
Glossitis, Benign Migratory
1
2018
2
0.170
Why?
Risperidone
1
2018
3
0.170
Why?
Databases as Topic
1
2018
23
0.170
Why?
Trifluoperazine
1
2018
4
0.170
Why?
Fatigue
2
2009
85
0.170
Why?
Population Surveillance
3
2010
124
0.170
Why?
Maternal Exposure
1
2018
13
0.160
Why?
CD4 Lymphocyte Count
1
2018
32
0.160
Why?
Virus Activation
1
2018
7
0.160
Why?
Immune Tolerance
1
2019
73
0.160
Why?
Red Cross
1
2018
2
0.160
Why?
Primates
1
2019
111
0.160
Why?
Asthma
2
2015
438
0.160
Why?
World Health Organization
1
2018
15
0.160
Why?
Skin Absorption
3
2009
9
0.160
Why?
Antiparasitic Agents
1
2018
6
0.160
Why?
Computer-Assisted Instruction
1
2018
24
0.160
Why?
Fees, Pharmaceutical
1
2018
2
0.160
Why?
Models, Organizational
1
2018
17
0.160
Why?
Expert Testimony
1
2018
11
0.160
Why?
Rhinophyma
1
2017
2
0.160
Why?
Adamantane
1
2017
3
0.160
Why?
Postoperative Complications
4
2014
788
0.160
Why?
Lidocaine
1
2018
18
0.150
Why?
Self-Help Groups
1
2017
11
0.150
Why?
Niacinamide
1
2017
8
0.150
Why?
Internal-External Control
1
2017
17
0.150
Why?
Epinephrine
1
2018
40
0.150
Why?
Keratinocytes
2
2015
30
0.150
Why?
Delivery of Health Care, Integrated
1
2018
33
0.150
Why?
Social Perception
1
2017
25
0.150
Why?
Information Services
2
2009
15
0.150
Why?
Genes, Essential
1
2017
4
0.150
Why?
Esophageal Neoplasms
1
2017
35
0.150
Why?
Oropharyngeal Neoplasms
1
2017
19
0.150
Why?
Gastrointestinal Diseases
1
2017
43
0.150
Why?
Pituitary-Adrenal System
1
2017
24
0.150
Why?
T-Lymphocytes, Cytotoxic
1
2017
36
0.150
Why?
Videodisc Recording
1
2017
4
0.150
Why?
Longitudinal Studies
7
2009
786
0.150
Why?
Markov Chains
1
2017
29
0.150
Why?
Tobacco
2
2008
57
0.150
Why?
Anesthetics, Local
1
2018
79
0.150
Why?
Coronary Disease
1
2018
215
0.150
Why?
Substance Withdrawal Syndrome
2
2009
61
0.150
Why?
Patient Advocacy
2
2008
13
0.140
Why?
Lentigo
2
2008
4
0.140
Why?
Immunoglobulin E
1
2017
50
0.140
Why?
Journalism, Medical
1
2016
2
0.140
Why?
Antineoplastic Agents
2
2014
611
0.140
Why?
African Continental Ancestry Group
4
2011
364
0.140
Why?
Quality Control
1
2016
43
0.140
Why?
Workers' Compensation
2
2006
3
0.140
Why?
Cattle
1
2016
101
0.130
Why?
Th2 Cells
1
2015
15
0.130
Why?
Minoxidil
1
2015
6
0.130
Why?
Interleukin-4
1
2015
22
0.130
Why?
Moving and Lifting Patients
1
2015
1
0.130
Why?
Probability
4
2009
160
0.130
Why?
Interleukin-13
1
2015
33
0.130
Why?
Electronic Prescribing
1
2015
2
0.130
Why?
Health Education
2
2007
157
0.130
Why?
Vasodilator Agents
1
2015
57
0.130
Why?
Botulinum Toxins
1
2015
37
0.130
Why?
Florida
2
2005
37
0.130
Why?
Canada
2
2013
56
0.130
Why?
Antibodies
1
2015
57
0.130
Why?
Emergency Medicine
1
2016
120
0.130
Why?
Ulcer
1
2014
3
0.130
Why?
Occlusive Dressings
1
2014
10
0.130
Why?
Radiotherapy
1
2015
82
0.130
Why?
Suspensions
1
2014
2
0.130
Why?
Medical Informatics
2
2007
27
0.130
Why?
Cyanoacrylates
1
2014
2
0.130
Why?
Teaching
1
2015
62
0.130
Why?
Hospital Costs
1
2015
38
0.130
Why?
Toes
1
2014
16
0.130
Why?
Musculoskeletal Diseases
1
2015
38
0.130
Why?
Oceanic Ancestry Group
1
2014
7
0.120
Why?
Thigh
1
2014
42
0.120
Why?
Antigens, CD19
1
2014
9
0.120
Why?
Immunotherapy, Adoptive
1
2014
12
0.120
Why?
Lymphoma, B-Cell
1
2014
11
0.120
Why?
Quinoxalines
1
2014
13
0.120
Why?
Hypericum
1
2014
2
0.120
Why?
Herb-Drug Interactions
1
2014
2
0.120
Why?
Receptors, Antigen, T-Cell
1
2014
27
0.120
Why?
Minocycline
1
2014
11
0.120
Why?
Education, Medical, Continuing
3
2014
57
0.120
Why?
Antibiotic Prophylaxis
1
2014
38
0.120
Why?
Pancytopenia
1
2014
3
0.120
Why?
Leukemia, Lymphoid
1
2014
3
0.120
Why?
Lymphoma, Large B-Cell, Diffuse
1
2014
16
0.120
Why?
Phosphodiesterase Inhibitors
1
2014
10
0.120
Why?
Resource Allocation
1
2014
10
0.120
Why?
Phosphoric Diester Hydrolases
1
2014
10
0.120
Why?
Single Person
1
2014
3
0.120
Why?
Unemployment
1
2014
4
0.120
Why?
Phytotherapy
1
2014
38
0.120
Why?
Medical Staff
1
2014
1
0.120
Why?
Tissue Distribution
1
2014
62
0.120
Why?
Sarcomeres
1
2014
3
0.120
Why?
NADPH Dehydrogenase
1
2014
2
0.120
Why?
Drug Interactions
1
2014
83
0.120
Why?
Cyclic AMP
1
2014
47
0.120
Why?
rho GTP-Binding Proteins
1
2014
10
0.120
Why?
Remission Induction
2
2005
84
0.120
Why?
Actigraphy
1
2014
13
0.120
Why?
Microtubule-Associated Proteins
1
2014
35
0.120
Why?
Health Personnel
1
2015
121
0.120
Why?
Mental Recall
1
2014
51
0.120
Why?
Polysomnography
1
2014
40
0.120
Why?
Triamcinolone Acetonide
1
2013
4
0.120
Why?
Microfilament Proteins
1
2014
35
0.120
Why?
Terminology as Topic
2
2005
65
0.120
Why?
Intracellular Signaling Peptides and Proteins
1
2014
73
0.110
Why?
Muscle Development
1
2014
48
0.110
Why?
Gasoline
1
2013
1
0.110
Why?
Lighting
1
2013
4
0.110
Why?
Biotechnology
1
2013
6
0.110
Why?
Drug Therapy, Computer-Assisted
1
2013
4
0.110
Why?
Feedback
1
2013
44
0.110
Why?
Osteoporosis
1
2014
57
0.110
Why?
Acyclovir
1
2013
13
0.110
Why?
Valine
1
2013
17
0.110
Why?
Medical Waste Disposal
1
2013
2
0.110
Why?
Herpes Simplex
1
2013
14
0.110
Why?
Keloid
1
2013
8
0.110
Why?
Needles
1
2013
31
0.110
Why?
Ketoconazole
1
2013
5
0.110
Why?
Dermatitis, Seborrheic
1
2013
4
0.110
Why?
Vitamins
1
2013
68
0.110
Why?
Equipment Failure Analysis
1
2013
43
0.110
Why?
International Classification of Diseases
1
2013
26
0.110
Why?
Carcinoma, Merkel Cell
1
2012
9
0.110
Why?
Sarcoma, Kaposi
1
2012
8
0.110
Why?
Otolaryngology
1
2013
18
0.110
Why?
Culture
1
2012
41
0.110
Why?
Carcinoma in Situ
1
2012
14
0.110
Why?
Myocardium
1
2014
196
0.110
Why?
Cumulative Trauma Disorders
1
2012
13
0.110
Why?
Fibroma
1
2012
10
0.110
Why?
Image Enhancement
1
2013
75
0.110
Why?
Housing
1
2013
64
0.110
Why?
Methylprednisolone
1
2012
13
0.100
Why?
Mexico
3
2007
69
0.100
Why?
Controlled Clinical Trials as Topic
2
2012
11
0.100
Why?
Attention Deficit Disorder with Hyperactivity
2
2018
36
0.100
Why?
Immunosuppression
1
2012
121
0.100
Why?
Confidence Intervals
2
2010
150
0.100
Why?
Proportional Hazards Models
1
2014
759
0.100
Why?
Fractures, Bone
1
2014
157
0.100
Why?
Hypercholesterolemia
1
2013
65
0.100
Why?
Liver Function Tests
1
2011
22
0.100
Why?
Puberty, Precocious
1
2011
1
0.100
Why?
Horses
1
2011
14
0.100
Why?
Specialty Boards
1
2011
10
0.100
Why?
Medicine, Traditional
2
2009
22
0.100
Why?
Milk
1
2011
13
0.100
Why?
Disinfection
1
2011
5
0.100
Why?
Drugs, Chinese Herbal
1
2011
7
0.100
Why?
Recurrence
2
2003
266
0.100
Why?
Wounds, Nonpenetrating
1
2012
90
0.100
Why?
Bandages
1
2011
34
0.100
Why?
Stress, Psychological
3
2009
218
0.100
Why?
Plasticizers
1
2010
1
0.100
Why?
Computer Terminals
1
2010
1
0.100
Why?
Latex Hypersensitivity
1
2010
1
0.100
Why?
Histamine H1 Antagonists
2
2008
9
0.100
Why?
Neoplasms, Radiation-Induced
1
2010
13
0.090
Why?
Immunohistochemistry
1
2012
545
0.090
Why?
Nurse Practitioners
1
2010
11
0.090
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2014
462
0.090
Why?
Total Quality Management
1
2010
18
0.090
Why?
Waiting Lists
2
2007
34
0.090
Why?
Carotid Stenosis
1
2011
60
0.090
Why?
Pathology, Clinical
1
2010
13
0.090
Why?
Smoking Cessation
1
2013
195
0.090
Why?
Time
1
2010
23
0.090
Why?
Pennsylvania
2
2018
84
0.090
Why?
Aging
1
2017
953
0.090
Why?
Durable Medical Equipment
1
2010
2
0.090
Why?
Ethics, Business
1
2010
2
0.090
Why?
Emigration and Immigration
2
2013
32
0.090
Why?
Conditioning, Classical
1
2010
26
0.090
Why?
Hygiene
2
2007
13
0.090
Why?
Hydroxides
1
2009
1
0.090
Why?
Mycology
1
2009
1
0.090
Why?
Potassium Compounds
1
2009
1
0.090
Why?
North Dakota
1
2009
3
0.090
Why?
Blood-Borne Pathogens
1
2009
7
0.090
Why?
Medical Audit
1
2009
16
0.090
Why?
Indicators and Reagents
1
2009
14
0.090
Why?
Specimen Handling
1
2009
35
0.090
Why?
Sample Size
2
2013
39
0.090
Why?
Dermatitis, Phototoxic
1
2009
2
0.090
Why?
Boston
1
2009
15
0.090
Why?
Observer Variation
2
2020
109
0.090
Why?
Deductibles and Coinsurance
1
2009
3
0.090
Why?
Sleep Apnea, Obstructive
1
2009
60
0.080
Why?
Beauty
1
2008
5
0.080
Why?
Rheumatic Diseases
1
2009
7
0.080
Why?
Neoplasms, Basal Cell
1
2008
2
0.080
Why?
Forecasting
3
2003
145
0.080
Why?
Arthralgia
1
2009
33
0.080
Why?
Organizational Objectives
1
2008
23
0.080
Why?
Signal Transduction
1
2012
701
0.080
Why?
Health Maintenance Organizations
2
2006
14
0.080
Why?
Adaptation, Physiological
1
2009
55
0.080
Why?
Electronics, Medical
1
2008
2
0.080
Why?
Microspheres
1
2008
44
0.080
Why?
Dermatitis, Irritant
1
2008
2
0.080
Why?
Sodium Hypochlorite
1
2008
3
0.080
Why?
Diagnostic Tests, Routine
1
2008
24
0.080
Why?
Detergents
1
2008
17
0.080
Why?
Acute Disease
2
2006
255
0.080
Why?
Eye Protective Devices
1
2008
6
0.080
Why?
Tuberculin Test
1
2007
2
0.080
Why?
Vision Disorders
1
2008
24
0.080
Why?
Radiotherapy Dosage
1
2008
101
0.080
Why?
Lichen Planus, Oral
1
2008
11
0.080
Why?
Toxoplasmosis, Animal
1
2007
1
0.080
Why?
Parent-Child Relations
2
2010
46
0.080
Why?
Leishmaniasis
1
2007
3
0.080
Why?
Receptors, Interleukin-12
1
2007
2
0.080
Why?
Injections, Intravenous
1
2007
79
0.080
Why?
Meta-Analysis as Topic
1
2007
43
0.080
Why?
Cryptococcosis
1
2007
5
0.080
Why?
Artifacts
1
2007
40
0.080
Why?
Drug Evaluation
2
2004
15
0.080
Why?
Behavior Therapy
1
2008
102
0.080
Why?
Prejudice
1
2007
50
0.080
Why?
Virus Diseases
1
2007
22
0.070
Why?
Ohio
1
2007
58
0.070
Why?
Communication Barriers
1
2007
22
0.070
Why?
Larva Migrans
1
2007
2
0.070
Why?
Drug Therapy
1
2007
16
0.070
Why?
Bacterial Infections
1
2007
52
0.070
Why?
Medical Staff, Hospital
1
2007
19
0.070
Why?
Microcomputers
1
2006
6
0.070
Why?
Models, Biological
1
2009
397
0.070
Why?
Chemistry, Pharmaceutical
1
2006
11
0.070
Why?
Focus Groups
2
2006
111
0.070
Why?
Predictive Value of Tests
1
2009
877
0.070
Why?
Vitamin A
1
2006
21
0.070
Why?
Lipectomy
2
2003
9
0.070
Why?
Hydroxyurea
1
2006
3
0.070
Why?
Eye Abnormalities
1
2006
4
0.070
Why?
Pterygium
1
2006
4
0.070
Why?
Radiation Dosage
2
2006
81
0.070
Why?
Social Adjustment
1
2006
8
0.070
Why?
Health Services Needs and Demand
1
2007
82
0.070
Why?
Skin Irritancy Tests
1
2005
1
0.070
Why?
Irritants
1
2005
2
0.070
Why?
Interferon-gamma
2
2017
63
0.070
Why?
Body Size
1
2005
32
0.070
Why?
Pleistophora
1
2005
1
0.070
Why?
Neoplasm Recurrence, Local
2
2008
370
0.070
Why?
Credentialing
1
2005
9
0.070
Why?
Dermatomyositis
1
2005
19
0.070
Why?
Drug Storage
1
2005
4
0.070
Why?
Candidiasis, Cutaneous
2
2002
2
0.070
Why?
Nicotine
1
2008
171
0.070
Why?
Poultry Products
1
2005
14
0.060
Why?
Child Health Services
1
2005
24
0.060
Why?
Respiratory Tract Diseases
1
2005
34
0.060
Why?
Family Health
1
2005
77
0.060
Why?
Educational Measurement
1
2006
119
0.060
Why?
Anesthesia
1
2005
64
0.060
Why?
Chemexfoliation
1
2004
2
0.060
Why?
Therapeutic Equivalency
1
2004
2
0.060
Why?
Texas
1
2004
36
0.060
Why?
Inpatients
1
2005
78
0.060
Why?
Reimbursement Mechanisms
1
2004
13
0.060
Why?
Urban Population
1
2005
87
0.060
Why?
Morbidity
1
2005
98
0.060
Why?
Hospital Mortality
1
2006
197
0.060
Why?
Primary Prevention
1
2004
54
0.060
Why?
Indians, North American
1
2004
109
0.060
Why?
Poultry
2
2014
27
0.060
Why?
Keratosis, Seborrheic
1
2003
1
0.060
Why?
Handwriting
1
2003
2
0.060
Why?
State Government
1
2003
32
0.060
Why?
Disaster Planning
1
2003
28
0.060
Why?
Rural Population
1
2005
274
0.060
Why?
Medicare Part A
1
2003
5
0.060
Why?
Medicare Part B
1
2003
5
0.060
Why?
Tonsillectomy
1
2003
10
0.050
Why?
Acrylic Resins
1
2002
2
0.050
Why?
Likelihood Functions
1
2002
48
0.050
Why?
Models, Psychological
1
2002
24
0.050
Why?
Drug Labeling
1
2002
3
0.050
Why?
Insurance, Health, Reimbursement
1
2002
16
0.050
Why?
Feasibility Studies
1
2003
294
0.050
Why?
Photosensitivity Disorders
1
2002
12
0.050
Why?
New York City
1
2002
14
0.050
Why?
Maryland
1
2002
28
0.050
Why?
Capitation Fee
1
2002
3
0.050
Why?
Tinea Versicolor
1
2002
1
0.050
Why?
Migraine Disorders
1
2003
65
0.050
Why?
California
1
2002
64
0.050
Why?
Body Mass Index
1
2005
921
0.050
Why?
Disability Evaluation
1
2003
236
0.050
Why?
Endpoint Determination
2
2013
21
0.050
Why?
Lasers
1
2002
21
0.050
Why?
Risk Reduction Behavior
1
2002
124
0.050
Why?
Preventive Health Services
1
2002
44
0.050
Why?
Asian Americans
1
2002
100
0.050
Why?
Disease-Free Survival
1
2002
320
0.050
Why?
Uncertainty
1
2021
13
0.050
Why?
Decision Support Techniques
1
2002
128
0.050
Why?
Visual Perception
1
2002
115
0.050
Why?
Disease Susceptibility
1
2021
58
0.050
Why?
Sleep Initiation and Maintenance Disorders
1
2021
53
0.050
Why?
Hypersensitivity
2
2014
27
0.050
Why?
Infectious Disease Medicine
1
2020
4
0.050
Why?
Epidemiology
1
2020
6
0.050
Why?
Propensity Score
1
2020
41
0.050
Why?
Advisory Committees
1
2020
37
0.050
Why?
Delphi Technique
1
2020
39
0.050
Why?
Genitalia
1
2020
8
0.050
Why?
Outpatient Clinics, Hospital
3
2007
16
0.050
Why?
Decontamination
1
2020
3
0.050
Why?
Equipment Reuse
1
2020
5
0.050
Why?
Virus Inactivation
1
2020
2
0.050
Why?
Telecommunications
1
2020
7
0.050
Why?
Masks
1
2020
5
0.050
Why?
Menopause
1
2021
92
0.050
Why?
Consensus Development Conferences as Topic
1
2020
10
0.050
Why?
Critical Care
1
2020
117
0.040
Why?
Commerce
1
2019
43
0.040
Why?
Iontophoresis
1
2019
6
0.040
Why?
Cholinergic Antagonists
1
2019
12
0.040
Why?
Skin Diseases, Bacterial
1
2018
3
0.040
Why?
Skin Diseases, Viral
1
2018
4
0.040
Why?
Sympathectomy
1
2019
22
0.040
Why?
Immunocompromised Host
1
2019
51
0.040
Why?
Coal Tar
2
2012
2
0.040
Why?
Interprofessional Relations
1
2019
51
0.040
Why?
New Jersey
1
2018
11
0.040
Why?
Half-Life
1
2018
22
0.040
Why?
Injections, Intradermal
1
2018
7
0.040
Why?
Antipruritics
1
2018
6
0.040
Why?
Anesthetics, Combined
1
2018
5
0.040
Why?
Anesthesia, Local
1
2018
17
0.040
Why?
Janus Kinase 1
1
2017
5
0.040
Why?
Knowledge Bases
1
2017
3
0.040
Why?
Receptors, Opioid, kappa
1
2018
40
0.040
Why?
Antigen Presentation
1
2017
10
0.040
Why?
Adoptive Transfer
1
2017
26
0.040
Why?
Genome
1
2017
38
0.040
Why?
Vaccination
1
2019
137
0.040
Why?
Histocompatibility Antigens Class I
1
2017
59
0.040
Why?
Smoking
2
2013
493
0.040
Why?
Area Under Curve
1
2016
95
0.030
Why?
Agrochemicals
2
2006
5
0.030
Why?
Pharmacies
1
2016
13
0.030
Why?
ROC Curve
1
2016
171
0.030
Why?
Sebum
1
2015
1
0.030
Why?
Sebaceous Glands
1
2015
2
0.030
Why?
Hair Follicle
1
2015
8
0.030
Why?
Nursing
1
2015
1
0.030
Why?
Blister
1
2015
7
0.030
Why?
Cell Line, Tumor
1
2017
736
0.030
Why?
Vidarabine
1
2014
6
0.030
Why?
Mutation
1
2017
503
0.030
Why?
Transplantation Conditioning
1
2014
13
0.030
Why?
Family
1
2015
115
0.030
Why?
Cyclophosphamide
1
2014
37
0.030
Why?
Neck
1
2014
26
0.030
Why?
Drug Utilization Review
2
2004
17
0.030
Why?
Azathioprine
1
2014
24
0.030
Why?
Equipment Safety
1
2014
20
0.030
Why?
Head
1
2014
49
0.030
Why?
Mycophenolic Acid
1
2014
40
0.030
Why?
Thiazolidines
1
2014
2
0.030
Why?
Actins
1
2014
53
0.030
Why?
Protein Isoforms
1
2014
58
0.030
Why?
Epidemiologic Studies
1
2013
20
0.030
Why?
Animals, Newborn
1
2014
116
0.030
Why?
Gene Expression Regulation, Developmental
1
2014
69
0.030
Why?
Environment
1
2013
52
0.030
Why?
Air Conditioning
1
2013
7
0.030
Why?
Humidity
1
2013
5
0.030
Why?
RNA, Small Interfering
1
2014
117
0.030
Why?
Group Practice
1
2013
3
0.030
Why?
Myocytes, Cardiac
1
2014
92
0.030
Why?
Private Practice
1
2013
4
0.030
Why?
Latin America
1
2013
8
0.030
Why?
Comparative Effectiveness Research
1
2012
25
0.030
Why?
Chickens
1
2012
38
0.030
Why?
Cell Differentiation
1
2014
468
0.020
Why?
Case Management
1
2011
5
0.020
Why?
Mice, Inbred C57BL
1
2014
773
0.020
Why?
Genetic Predisposition to Disease
1
2013
849
0.020
Why?
Reference Values
1
2010
255
0.020
Why?
Motivation
1
2010
114
0.020
Why?
Office Management
1
2007
2
0.020
Why?
Self Disclosure
1
2008
23
0.020
Why?
Time Management
1
2007
9
0.020
Why?
Hyperplasia
1
2007
38
0.020
Why?
Epidermis
1
2007
30
0.020
Why?
Leisure Activities
1
2007
13
0.020
Why?
Knowledge
1
2007
16
0.020
Why?
Minnesota
1
2006
21
0.020
Why?
Rural Health
1
2007
44
0.020
Why?
Rhode Island
1
2006
5
0.020
Why?
Insect Bites and Stings
1
2006
3
0.020
Why?
Plants
1
2006
6
0.020
Why?
Infusions, Intravenous
1
2006
100
0.020
Why?
Cross-Over Studies
1
2006
101
0.020
Why?
Cinnamates
1
2006
5
0.020
Why?
Chalcones
1
2006
3
0.020
Why?
Propiophenones
1
2006
4
0.020
Why?
Water
1
2006
57
0.020
Why?
Dose-Response Relationship, Radiation
1
2006
78
0.020
Why?
Workplace
1
2006
47
0.020
Why?
Sunburn
1
2005
2
0.020
Why?
Air Pollutants, Occupational
1
2005
4
0.020
Why?
Diagnosis-Related Groups
1
2005
11
0.020
Why?
Dermabrasion
1
2004
2
0.020
Why?
Teratogens
1
2004
3
0.020
Why?
Writing
1
2004
13
0.010
Why?
Statistics as Topic
1
2004
110
0.010
Why?
Comprehension
1
2003
21
0.010
Why?
Dihydroxycholecalciferols
1
2003
1
0.010
Why?
Anthralin
1
2003
2
0.010
Why?
Survival Rate
1
2005
894
0.010
Why?
Long-Term Care
1
2003
25
0.010
Why?
Diaper Rash
1
2002
1
0.010
Why?
Postoperative Period
1
2002
100
0.010
Why?
Time and Motion Studies
1
2002
5
0.010
Why?
Feldman's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (1170)
Explore
_
Co-Authors (35)
Explore
_
Similar People (52)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_